InvestorsHub Logo
Followers 165
Posts 19913
Boards Moderated 2
Alias Born 12/09/2004

Re: BIOChecker4 post# 463152

Tuesday, 07/02/2024 4:50:17 PM

Tuesday, July 02, 2024 4:50:17 PM

Post# of 464602
You keep claiming Missling is a failed CEO and pushing that story day in and day out.

I, for one, disagree with you on that. Is he perfect? No. Has he managed the company finances well? Very well.

If the Rett trial had not had the unexpected outcome Anavex would be $40+ stock and Missling would be viewed as a great CEO.

And as far as missing out on a bull market, not me. I am quite happy with the position I have amassed in Anavex over the years. It is my high risk money so it in the unlikely event that Anavex fails my life style will not change a bit. If it succeeds my life style will change.

Missling has Anavex well positioned with no debt, multiple drugs in the pipeline and the approval process started for one of the biggest diseases in the CNS space.
So keep pounding on that drum. It isn't going to make a lick of difference. Missling has gotten Anavex to the point that trial results are all that matter.

Nunc est Bibendum

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News